System Maintenance Notice

Please note that maintenance work is scheduled between 4 AM and 5 AM - CET. During this time, you may experience reduced performance. Thanks for your patience.

Publications

Journal Article Research Support, Non-U.S. Gov't Review Epublish 17 citations

PubMed: 35003137 DOI: 10.3389/fimmu.2021.808064

Global Perspectives on Immunization Against SARS-CoV-2 During Pregnancy and Priorities for Future Research: An International Consensus Paper From the World Association of Infectious Diseases and Immunological Disorders.

Front Immunol 12:808064

Authors: Bahaa Abu-Raya, Shabir A Madhi, Saad B Omer, Gayatri Amirthalingam, Michelle L Giles, Katie L Flanagan, Petra Zimmermann, Miguel O'Ryan, Marco A Safadi, Vassiliki Papaevangelou, Kirsten Maertens, Nasamon Wanlapakorn, Vicens Diaz-Brito, Eline Tommelein, Susanna Esposito

Affiliations

  • Department of Pediatrics, University of British Columbia, Vancouver, BC, Canada.
  • South African Medical Research Council, Vaccines and Infectious Diseases Analytics Research Unit, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa.
  • African Leadership in Vaccinology Expertise, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa.
  • Department of Internal Medicine (Infectious Diseases), Yale School of Medicine, New Haven, CT, United States.
  • Department of Epidemiology of Microbial Diseases, Yale School of Public Health, New Haven, CT, United States.
  • Immunisation and Countermeasures Division, National Infection Service, Public Health England, London, United Kingdom.
  • Department of Obstetrics and Gynaecology, Monash University, Melbourne, VIC, Australia. Department of Infectious Diseases, Peter Doherty Institute for Infection and Immunity, Melbourne, VIC, Australia.
  • School of Medicine, Faculty of Health Sciences, University of Tasmania, Launceston, TAS, Australia.
  • School of Health and Biomedical Science, Royal Melbourne Institute of Technology (RMIT) University, Melbourne, VIC, Australia.
  • Department of Immunology and Pathology, Monash University, Melbourne, VIC, Australia.
  • Tasmanian Vaccine Trial Centre, Clifford Craig Foundation, Launceston General Hospital, Launceston, TAS, Australia.
  • Faculty of Science and Medicine, University of Fribourg, Fribourg, Switzerland.
  • Department of Paediatrics, Fribourg Hospital HFR, Fribourg, Switzerland.
  • Microbiology and Mycology Program, Institute of Biomedical Sciences and Millennium Institute of Immunology and Immunotherapy, Faculty of Medicine, University of Chile, Santiago de Chile, Chile.
  • Department of Pediatrics, Santa Casa de Sao Paulo School of Medical Sciences, Sao Paulo, Brazil.
  • National and Kapodistrian University of Athens, Third Department of Pediatrics, University Hospital Attikon, Athens, Greece.
  • Centre for the Evaluation of Vaccination, Vaccine & Infectious Diseases Institute, Faculty of Medicine and Health Sciences, University of Antwerp, Antwerp, Belgium.
  • Center of Excellence in Clinical Virology, Department of Pediatrics, Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand.
  • Department of Infectious Diseases, Parc Sanitari Sant Joan de Déu,, Barcelona, Spain.
  • Department of Pharmacy, Faculty of Medicine and Pharmacy, Vrije Universiteit Brussel, Brussels, Belgium.
  • Pediatric Clinic, Pietro Barilla Children's Hospital, Department of Medicine and Surgery, University of Parma, Parma, Italy.

Abstract

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection in pregnancy is associated with a higher risk for severe morbidity and mortality when compared with infection in non-pregnant women of childbearing age. An increasing number of countries recommend immunization against SARS-CoV-2 in pregnant women. Recent studies provide preliminary and supportive evidence on safety, immunogenicity and effectiveness of coronavirus disease 2019 (COVID-19) vaccines in pregnant women; however, important knowledge gaps remain which warrant further studies. This collaborative consensus paper provides a review of the current literature on COVID-19 vaccines in pregnant women, identifies knowledge gaps and outlines priorities for future research to optimize protection against SARS-CoV-2 in the pregnant women and their infants.

MeSH

Pregnant Women, Coronavirus, Pregnancy, Sars-Cov-2, Immunization, Vaccines, Covid-19, Immune System Diseases, Research, Severe Acute Respiratory Syndrome-Related Coronavirus, Communicable Diseases, Infections

Cited by